Platelet-derived growth factor receptor regulates myeloid and monocytic differentiation of HL-60 cells

Cancer Research

Volumn 67, Issue 16, 2007, Pages 7765-7772

  Reiterer, Gudrun ^a   Yen, Andrew ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6,7 DIMETHOXY 2 PHENYLQUINOXALINE; CALCIUM; CD11B ANTIGEN; CD14 ANTIGEN; CD38 ANTIGEN; CELL MARKER; COLECALCIFEROL; MITOGEN ACTIVATED PROTEIN KINASE 1; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; RETINOIC ACID;

AEROBIC METABOLISM; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HL 60; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD; ANTIGENS, CD11B; ANTIGENS, CD14; ANTIGENS, CD38; CALCIUM; CELL ADHESION; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CHOLECALCIFEROL; G0 PHASE; HL-60 CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MONOCYTES; MYELOID CELLS; PHOSPHORYLATION; RECEPTORS, FC; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; TRETINOIN; TYRPHOSTINS; UBIQUITIN;

EID: 34548013939     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-0014     Document Type: Article

References (27)

1. Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003;348:1201-14.
2. Golub TR, Barker GF, Lovett M, Gilliland DG. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994;77:307-16.
3. Magnusson MK, Meade KE, Brown KE, et al. Rabaptin-5 is a novel fusion partner to platelet-derived growth factor β receptor in chronic myelomonocytic leukemia. Blood 2001;98:2518-25.
4. Ostman A, Heldin CH. Involvement of platelet-derived growth factor in disease: development of specific antagonists. Adv Cancer Res 2001;80:1-38.
5. Apperley JF, Gardembas M, Melo JV, et al. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor β. N Engl J Med 2002;347:48-7.
6. Maki RG, Awan RA, Dixon RH, Jhanwar S, Antonescu CR. Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans. Int J Cancer 2002;100:623-6.
7. Pietras K, Sjoblom T, Rubin K, Heldin CH, Ostman A. PDGF receptors as cancer drug targets. Cancer Cell 2003;3:439-43.
8. Betsholtz C, Karlsson L, Lindahl P. Developmental roles of platelet-derived growth factors. BioEssays 2001;23:494-507.
9. Dubois-Dalcq M, Murray K. Why are growth factors important in oligodendrocyte physiology? Pathol Biol (Paris) 2000;48:80-6.
10. Artemenko Y, Gagnon A, Aubin D, Sorisky A. Antiadipogenic effect of PDGF is reversed by PKC inhibition. J Cell Physiol 2005;204:646-53.
11. Tamama K, Fan VH, Griffith LG, Blair HC, Wells A. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells 2006;24:686-95.
12. Li K, Li CK, Chuen CK, et al. Preclinical ex vivo expansion of G-CSF-mobilized peripheral blood stem cells: effects of serum-free media, cytokine combinations and chemotherapy. Eur J Haematol 2005;74:128-35.
13. Yoshida H, Takakura N, Hirashima M, et al. Hematopoietic tissues, as a playground of receptor tyrosine kinases of the PDGF-receptor family. Dev Comp Immunol 1998;22:321-32.
14. Tsiftsoglou AS, Pappas IS, Vizirianakis IS. Mechanisms involved in the induced differentiation of leukemia cells. Pharmacol Ther 2003;100:257-90.
15. Yen A, Forbes M, DeGala G, Fishbaugh J. Control of HL-60c ell differentiation lineage specificity, a late event occurring after precommitment. Cancer Res 1987;47:129-34.
16. Yen A, Brown D, Fishbaugh J. Control of HL-60 monocytic differentiation. Different pathways and uncoupled expression of differentiation markers. Exp Cell Res 1987;168:247-54.
17. Levitzki A. PDGF receptor kinase inhibitors for the treatment of PDGF driven diseases. Cytokine Growth Factor Rev 2004;15:229-35.
18. Di Noto R, Lo Pardo C, Schiavone EM, et al. All-trans-retinoic acid (ATRA) and the regulation of adhesion molecules in acute myeloid leukemia. Leuk Lymphoma 1996;21:201-9.
19. Sun L, Iqbal J, Zaidi S, et al. Structure and functional regulation of the CD38 promoter. Biochem Biophys Res Commun 2006;341:804-9.
20. 2+ transients in human myometrium cells. Endocrinology 2004;145:881-9.
21. Woollard KJ, Fisch C, Newby R, Griffiths HR. C-reactive protein mediates CD11b expression in monocytes through the non-receptor tyrosine kinase, Syk, and calcium mobilization but not through cytosolic peroxides. Inflamm Res 2005;54:485-92.
22. Kawagoe H, Grosveld GC. MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice. Blood 2005;106:4278-86.
23. Miyake S, Lupher ML, Jr., Druker B, Band H. The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor α. Proc Natl Acad Sci U S A 1998;95:7927-32.
24. 2+ release channels downregulates CD38 in the Namalwa B lymphoma. FEBS Lett 2003;554:133-7.
25. Bornfeldt KE, Raines EW, Graves LM, Skinner MP, Krebs EG, Ross R. Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation. Ann N Y Acad Sci 1995;766:416-30.
26. Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA. JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 2004;18:189-218.
27. Lee-Chiong T, Jr., Matthay RA. Drug-induced pulmonary edema and acute respiratory distress syndrome. Clin Chest Med 2004;25:95-104.